产品编号 :
Cas No. :
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 1mg | 98% | 现货 | |||
| 5mg | 98% | 现货 | |||
| 10mg | 98% | 现货 | |||
| 50mg | 98% | 现货 | |||
| 100mg | 98% | 现货 | |||
| 250mg | 98% | 现货 | |||
| 1g | 98% | 现货 |
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 1mg | 98% | 现货 | |||
| 5mg | 98% | 现货 | |||
| 10mg | 98% | 现货 | |||
| 50mg | 98% | 现货 | |||
| 100mg | 98% | 现货 | |||
| 250mg | 98% | 现货 | |||
| 1g | 98% | 现货 |
CAS No. |
726169-73-9 |
|---|---|
中文名称 |
N-(2-氨基苯基)-4 - (((4-(吡啶-3-基)嘧啶-2-基)氨基)甲基)苯甲酰胺 |
英文名称 |
N-(2-Aminophenyl)-4-(((4-(pyridin-3-yl)pyrimidin-2-yl)amino)methyl)benzamide |
别名 |
MFCD10565970 | MGCD0103 - Mocetinostat | NCGC00263182-11 | UNII-A6GWB8T96J | DTXSID80222945 | HMS3426I07 | STK387500 | SCHEMBL157027 | AKOS015916602 | MG 0103 | BRD-K16485616-001-04-8 | FT-0627651 | HRNLUBSXIHFDHP-UHFFFAOYSA-N | MOCETINOSTAT [INN] | N-(2- |
标准英文名 |
N-(2-aminophenyl)-4-(((4-(pyridin-3-yl)pyrimidin-2-yl)amino)methyl)benzamide |
分子式 |
C23H20N6O |
分子量 |
396.45 |
精确分子量 |
396.17 |
SMILES |
O=C(NC1=CC=CC=C1N)C2=CC=C(CNC3=NC=CC(C4=CC=CN=C4)=N3)C=C2 |
标准SMILES |
NC1=CC=CC=C1NC(=O)C1C=CC(CNC2N=C(C=CN=2)C2=CC=CN=C2)=CC=1 |
性状 |
Light yellow to yellow powder or crystals |
用途 |
For laboratory research purposes. Not for drug or household use. |
信号词 |
Warning |
InChIKey |
HRNLUBSXIHFDHP-UHFFFAOYSA-N |
危险类别(旧) |
H302,H315,H319,H335 |
存储要求 |
Sealed in dry,2-8°C,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage. |
危险品分类 |
Acute toxicity, oral (Category 4),Skin corrosion/irritation (Category 2),Serious eye damage/eye irritation (Category 2A ),Specific target organ toxicity, single exposure;Respiratory system (Category 3) |
|---|---|
化学稳定性 |
Stable under recommended storage conditions. |
符号 |
|
|
|
评论 |
|---|